Please assess the completion status of the following clinical trial:

Trial Title: Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Subjects with community-acquired pneumonia requiring:~* initial hospitalization or treatment in an emergency room or urgent care setting~* infection requiring initial treatment with IV antimicrobial~Exclusion Criteria:~* Community-acquired pneumonia suitable for outpatient therapy with an oral antimicrobial agent~* Respiratory tract infections not due to community-acquired bacterial pathogens~* Infections resistant to ceftriaxone~* Any condition requiring concomitant systemic corticosteroids~* History of any hypersensitivity or allergic reaction to any ß-lactam antimicrobial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ceftaroline fosamil for injection (Type: EXPERIMENTAL): Ceftaroline fosamil was administered in two consecutive 300 mg IV infusions over 30 minutes, every 12 hours (q12h).
- IV Ceftriaxone (Type: ACTIVE_COMPARATOR): Ceftriaxone was administered as a 1-g IV infusion over 30 minutes followed by IV saline placebo infused over 30 minutes, every 24 hours (q24h).

Based on this trial design, predict the completion outcome and termination type (if applicable).